Sponsor:
Boehringer Ingelheim
Code:
NCT07850050
Conditions
Obesity
Eligibility Criteria
Sex: Female
Age: 45 - 65
Healthy Volunteers: Not accepted
Interventions
Survodutide
Placebo
Brief summary:
Conditions
Obesity
Study ID
NCT07850050
Start date
Nov 25, 2026
Status verified date
Nov, 2026
Completion date
Jul 26, 2028
Anticipated
Primary completion date
Jul 26, 2028
Anticipated
Eligibility Criteria
Sex: Female
Age: 45 - 65
Healthy Volunteers: Not accepted
Enrollment
600 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Survodutide arm
placebo comparator: Placebo arm
Interventions
Survodutide
Placebo
Primary outcome measure
Central contacts
Locations
The Center for Diabetes and Endocrine Care
Recruiting
Fort Lauderdale, Florida, United States, 33312
Contacts
Flourish Research
Recruiting
Merritt Island, Florida, United States, 32952
Contacts
West Orange Endocrinology, PA
Recruiting
Ocoee, Florida, United States, 34761
Contacts
Sponsor
Boehringer Ingelheim
Last update posted
Nov 18, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Boehringer Ingelheim on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.